CONMED
No price chart data available for 1D timeframe.
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of sur...
Latest News
4 days ago · zacks.com
Here's Why You Should Retain CONMED Stock in Your Portfolio for NowCONMED's AirSeal, Buffalo Filter and BioBrace platforms offer growth opportunities, while rising robotic procedures and ASC adoption support its long-term prospects despite tariff and operational headwinds.
14 days ago · businesswire.com
CONMED Corporation to Participate in the Jefferies Global Healthcare ConferenceLARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Jefferies Global Healthcare Conference, which is being held November 16-19, 2026 at the Waldorf Hilton and ME Hotel in London, UK. Management will participate in a fireside chat on Monday, November 16th at 11:30 a.m. Greenwich Mean Time (6:30 a.m. Eastern Time). A live audio webcast of the fireside chat will be accessible under the “Events” section of the company's investor relations website:.
19 days ago · marketbeat.com
CONMED Q3 Earnings Call HighlightsCONMED NYSE: CNMD reported third-quarter 2026 revenue of $335.6 million, with organic constant-currency sales growth of 6.7% as the medical technology company cited broad-based contributions from its general surgery and orthopedic surgery businesses.
19 days ago · seekingalpha.com
CONMED Corporation (CNMD) Q3 2026 Earnings Call TranscriptCONMED Corporation ( CNMD ) Q3 2026 Earnings Call October 28, 2026 4:30 PM EDT Company Participants Patrick Beyer - President, CEO & Director John Gallagher - Executive VP, CFO and Principal Financial & Accounting Officer Conference Call Participants Anton Heldmann - BMO Capital Markets Equity Research Ross Osborn - Wells Fargo Securities, LLC, Research Division Matthew O'Brien - Piper Sandler & Co., Research Division Michael Matson - Needham & Company, LLC, Research Division Robert Marcus - JPMorgan Chase & Co, Research Division Travis Steed - BofA Securities, Research Division Young Li - Jefferies LLC, Research Division Presentation Operator Hello, and welcome to CONMED's Third Quarter of 2026 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
19 days ago · zacks.com
Conmed (CNMD) Q3 Earnings Top EstimatesConmed (CNMD) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $1 per share. This compares to earnings of $1.08 per share a year ago.
19 days ago · zacks.com
Here's What Key Metrics Tell Us About Conmed (CNMD) Q3 EarningsWhile the top- and bottom-line numbers for Conmed (CNMD) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
1 month ago · gurufocus.com
Is Conmed Corp (CNMD) a Bargain After 6.0% Drop? GF Value Says UndervaluedOn October 06, 2026, Conmed Corp (CNMD) shares fell 6.0% to a current price of $44.48, marking a significant decline in the context of a 52-week range of $31.44
2 months ago · businesswire.com
CONMED Corporation to Report Third Quarter 2026 Financial Results on October 28, 2026LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2026 after the market close on Wednesday, October 28, 2026. The Company's management will host a conference call at 4:30 p.m. ET that same day to discuss the results. To participate in the conference call via live webcast, please click here. To participate via telephone, please click here to pre-register and obtain the dial-in number and passcode. This confer.
3 months ago · zacks.com
Conmed (CNMD) Up 7.1% Since Last Earnings Report: Can It Continue?Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?
3 months ago · businesswire.com
CONMED Corporation to Participate in the Wells Fargo 21st Annual Healthcare ConferenceLARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced its participation in the Wells Fargo 21st Annual Healthcare Conference, which is being held September 8-10, 2026 at the Encore Boston Harbor in Everett, MA. Management will participate in a fireside chat on Wednesday, September 9th at 1:30 p.m. Eastern Time. A live audio webcast of the fireside chat will be accessible under the “Events” section of the company's investor relations website: https://www.conmed.com/en/inv.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove CNMD